Volume 2 Supplement 1

4th International Conference on Conservative Management of Spinal Deformities

Open Access

Outcomes of brace treatment for adolescent idiopathic scoliosis

  • Toru Maruyama1Email author,
  • Makoto Miura1,
  • Gou Sasaki1 and
  • Tomoaki Kitagawa1
Scoliosis20072(Suppl 1):S17

https://doi.org/10.1186/1748-7161-2-S1-S17

Published: 12 October 2007

Objective

To analyze outcomes of brace treatment for adolescent idiopathic scoliosis (AIS) in a retrospective fashion.

Study design

The subjects of the study were patients with AIS, whose Cobb angle was larger than 25 degrees and Risser sign was smaller than 3 at the start of the treatment, and who were followed for more than one year and at least until Risser sign of 4. Cervico-thoraco-lumbo-sacral orthosis (CTLSO) was used for thoracic curves and thoraco-lumbo-sacral orthosis (TLSO) was used for thoracolumbar and lumbar curves.

Results

The study sample consisted of thirty-nine girls, whose average age was 12.8 years and average Cobb angle was 37 degrees at the start of the treatment. The average curve magnitude increased to 45.4 degrees after a follow-up period of 2.8 years. Curve magnitude of eleven patients (28%) increased more than 10 degrees: in the remaining twenty-eight patients (72%) the change of their curve was ≤10 degrees. Presence of menarche, rib hump magnitude, and initial correction rate by the brace were the factors affecting the results.

Conclusion

Results of the brace treatment were better than the natural history reported by Bunnell [1]. The outcomes of the brace treatment for AIS may be improved if the correction by the brace can be improved.

Authors’ Affiliations

(1)
Department of Orthopaedic Surgery, Saitama Medical Center, Saitama Medical University

References

  1. Bunnell WP: The natural history of IS before skeletal maturity. Spine. 1986, 11: 773-776. 10.1097/00007632-198610000-00003.View ArticlePubMedGoogle Scholar

Copyright

© Maruyama et al; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd.

Advertisement